Sort
40,608 grants matching “prostate cancer”
Active H+ Transport in Urinary Acidification
$359,231Qais Al-Awqati · Columbia University Health Sciences · R01 · FY2006 · DK
Novel 3-dimensional (3-D) platform for high-throughput glycomics analysis
$359,198Jian Zhang · Ada Technologies, Inc. · R44 · FY2011 · RR
Molecular Determinants of Androgen Receptor Pharmacology
$359,188Donald P McDonnell · Duke University · R01 · FY2010 · CA
Dissecting the Role of Proteostasis in Anti-Androgen Resistant Prostate Cancer
$359,138Chengfei Liu · University Of California At Davis · R37 · FY2021 · CA
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
$359,138Xiaolin Zi · University Of California-Irvine · R01 · FY2025 · CA
Nanotechnology enabled targeting of p53 deficiency in human cancer
$359,138Xiaoming He · Ohio State University · R01 · FY2017 · CA
Stimuli-responsive crosslinked theranostics against advanced prostate cancer
$359,138Yuanpei Li · University Of California At Davis · R01 · FY2018 · CA
Targeting key orphan nuclear receptor in lethal prostate cancer
$359,138Hongwu Chen · University Of California At Davis · R01 · FY2020 · CA
Dissecting the Role of Proteostasis in Anti-Androgen Resistant Prostate Cancer
$359,138Chengfei Liu · University Of California At Davis · R37 · FY2022 · CA
Stimuli-responsive crosslinked theranostics against advanced prostate cancer
$359,138Yuanpei Li · University Of California At Davis · R01 · FY2016 · CA
Stimuli-responsive crosslinked theranostics against advanced prostate cancer
$359,138Yuanpei Li · University Of California At Davis · R01 · FY2017 · CA
Targeting key orphan nuclear receptor in lethal prostate cancer
$359,138Hongwu Chen · University Of California At Davis · R01 · FY2018 · CA
Targeting key orphan nuclear receptor in lethal prostate cancer
$359,138Hongwu Chen · University Of California At Davis · R01 · FY2017 · CA
Dissecting the Role of Proteostasis in Anti-Androgen Resistant Prostate Cancer
$359,138Chengfei Liu · University Of California At Davis · R37 · FY2025 · CA
NOVEL FUNCTIONS OF THE VITAMIN D RECEPTOR AND DISEASE
$359,123Mark R Haussler · University Of Arizona · R01 · FY2007 · DK
Modulating HSP70/STUB1 machinery in therapy-resistant prostate cancer
$359,098Chengfei Liu · University Of California At Davis · R01 · FY2025 · CA
Quantitative Mass Spectrometry
$359,019Kenneth Tomer · Environmental Health Sciences · Z01 · FY2007 · ES
Decision Aids to Address Prostate Cancer Disparities in Minority Men
$359,003Jon C Tilburt · Mayo Clinic Rochester · R01 · FY2016 · MD
The role of weak multivalent interactions and phase separation in SPOP tumor suppressor function
$359,000Tanja Mittag · St. Jude Children'S Research Hospital · R01 · FY2020 · GM
The role of weak multivalent interactions and phase separation in SPOP tumor suppressor function
$359,000Tanja Mittag · St. Jude Children'S Research Hospital · R01 · FY2023 · GM
The role of weak multivalent interactions and phase separation in SPOP tumor suppressor function
$359,000Tanja Mittag · St. Jude Children'S Research Hospital · R01 · FY2022 · GM
The role of weak multivalent interactions and phase separation in SPOP tumor suppressor function
$359,000Tanja Mittag · St. Jude Children'S Research Hospital · R01 · FY2021 · GM
Genetic Epidemiology of Prostate Cancer Risk and Progression
$358,978John S Witte · University Of California, San Francisco · R01 · FY2014 · CA
Targeting AR variants in advanced prostate cancer
$358,955Allen C Gao · University Of California At Davis · R01 · FY2020 · CA
Targeting AR variants in advanced prostate cancer
$358,955Allen C Gao · University Of California At Davis · R01 · FY2021 · CA